Chinese National Human Genome Center

Chinese National Human Genome Center

Chinese National Human Genome Center, Beijing , was established as one of the national-level genome research center approved by the Ministry of Science & Technology. CHGB promotes the commercialization of research products and initiate genome industry in China. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Chinese National Human Genome Center, China, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

61%


Total
Publications

921


Total Open
Publications

564


Total
Citations

70K


Open Access
Percentage

61%


Total
Publications

921


Total Open
Publications

564


Total
Citations

70K

Wikipedia

Website

download

Breakdown

16% 38% 7% 39%

Publisher Open

16%

Both

38%

Other Platform Open

7%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

49%OA Journal

OA Journal 49%

246

Hybrid 21%

105

No Guarantees 30%

149

Other Platform Open

Domain 93%

387

Public 22%

91

Institution 7%

31

Other Internet 6%

23

Preprint 4%

18

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
388
Europe PMC
Domain
254
Semantic Scholar
Public
83
Figshare
Public
26
DOI
Other Internet
15
University of Dundee - Discovery Research Portal
Institution
13
University of Bristol - Bristol Research
Institution
13
Research Square
Preprint
10
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
8
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
8
1 / 7

Data updated 8 December 2024

Share

Share

Share